Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Concord Biotech Limited, is an unlisted public company incorporated on 23 November, 1984. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 11.00 cr and the total paid-up capital is INR 10.46 cr.
Concord Biotech Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2022. It's EBITDA has decreased by 16.46% over the previous year. At the same time, it's book networth has increased by 10.75%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Ravi Kapoor
Shareholder
|
00003847 | 21 years |
Director | Amitabh Gajendra Thakore | 00016715 | 8 years |
Managing Director | Sudhir Jairam Vaid
Shareholder
|
00055967 | 14 years |
Director | Utpal Hemendra Sheth | 00081012 | 15 years |
Director | Arvind Motilal Agarwal | 00122921 | 3 years |
Director | Rajiv Ambrish Agarwal
Shareholder
|
00379990 | 17 years |
Managing Director | Ankur Vaid
Shareholder
|
01857225 | 15 years |
Director | Jayaram Easwaran | 02241192 | 3 years |
CFO | Lalit Jiwan Sethi | <HIDDEN> | 3 years |
Director | Bharti Khanna | 05147844 | 8 years |
Director | Chakravarthy Sriraman Mandayam | 09631555 | 3 years |
CS | Prakash Lalchand Sajnani
Shareholder
|
<HIDDEN> | 21 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 110.0 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 45.0 cr
Read more
The incorporation date of CONCORD BIOTECH LIMITED is 23 November, 1984
The authorized share capital of CONCORD BIOTECH LIMITED is INR ₹ 11.0 Cr.
The paid-up capital of CONCORD BIOTECH LIMITED is INR ₹ 10.5 Cr.
The registered address of CONCORD BIOTECH LIMITED is 1482-86 TRASAD ROAD DHOLKA NA AHMEDABAD Gujarat - 387810
The CIN number of CONCORD BIOTECH LIMITED is U24230GJ1984PLC007440.